What is the APLS stock price prediction for next 2 weeks?

According to our price prediction algorithm,Apellis Pharmaceuticals, Inc. (APLS) price will be around $19.50 in the next 2 weeks. This means it will decrease by -3.2624007936507855 from the last closing price. This prediction may vary from other time period filters for APLS stock.

What can be the highest Possible price of APLS stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, APLS can achieve the highest price of $20.30 which is 0.7170531264095761 higher than last closing price. This prediction may vary from other time period filters for APLS stock.

What can be the lowest Possible price of APLS stock in next 2 weeks?

As per the forecast and algorithmic analysis, APLS stock price can be as low as $18.67 which is -7.396783972742446 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for APLS stock.

Will APLS stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that APLS stock will lose-3.2624007936507855 in the next 2 weeks. This prediction may vary from other time period filters for APLS stock.

What is APLS stock last closing price?

Last closing price of APLS stock was $20.16.

What is APLS stock price prediction?

APLS stock price prediction means predicting the future closing prices of APLS stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of APLS stock in a certain time period.

How we predict APLS stock future prices?

If you are searching for APLS stock forecast, analysis or price prediction, then you might be wondering what Apellis Pharmaceuticals, Inc. (APLS) will do in the future. Our APLS price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This APLS price prediction will likely answer most of your questions.

How frequent we update APLS stock predictions?

We are updating the forecasts for the APLS stock on daily basis.

Is using ML forecasting for APLS stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for APLS stock same for all the time periods?

No, the prediction for APLS stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Apellis Pharmaceuticals, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$20.16-9.19%Since 2 Weeks

Predicted Price$19.50-3.26%For 2 Weeks

Upper Predicted Price$20.300.72%For 2 Weeks

Lower Predicted Price$18.67-7.4%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of APLS will decline by -3.26% over the next 2 Weeks and hit $19.50 by Tuesday, March 17, 2026. In that time frame, APLS's share price is expected to range between $18.67 and $20.30.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Mar 17, 2026	18.67	19.50	20.30
Mar 16, 2026	19.47	20.27	21.05
Mar 13, 2026	18.76	19.53	20.29
Mar 12, 2026	19.05	19.86	20.61
Mar 11, 2026	19.02	19.74	20.51
Mar 10, 2026	19.00	19.78	20.51
Mar 9, 2026	19.76	20.54	21.27
Mar 6, 2026	19.00	19.80	20.60
Mar 5, 2026	19.41	20.13	20.91
Mar 4, 2026	19.19	20.01	20.72

APLS shares fell -2.61% in Tuesday, March 3, 2026's trading session, dropping from a previous close of $20.70 to move at $20.16. The stock demonstrated notable intraday movement (see APLS's key stats for a full breakdown), fluctuating between $20.02 and $20.62, a +3.00% trading range. While recent weeks have seen some volatility, APLS has managed to secure a -9.19% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 1.41M shares changing hands, 208.44K fewer than the previous session. This amounted to $28.48M in total market activity.

Will APLS Continue Its Upward Trend?

According to analyst ratings and projections for APLS, Apellis Pharmaceuticals, Inc. shares are anticipated to increase by +0.71%, potentially reaching $20.30 per share by March 17, 2026. Short-term technical indicators currently suggest a neutral sentiment for APLS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the APLS stock forecast, now is a good time to buy APLS stock because its current trading price is +3.37% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on APLS covering social and institutional perspectives.

APLS Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into APLS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 28.49% to 39.33%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 45.50%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.19%, maintains a neutral outlook for the long term. Insights into APLS's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Apellis Pharmaceuticals Short-Term Forecasts

APLS Forecast For Next 5 Days

Our algorithm anticipates Apellis Pharmaceuticals (APLS) stock could hit $23.63 by Mar 10, 2026. This represents a +17.19% fall from today's price, following a -11.77% change over the past five days.

APLS Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Apellis Pharmaceuticals, Inc. (APLS) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $21.63, which would mean a +7.29% increase from the current price of $20.16. Projections for this period range from a high of $25.29 to a low of $18.43.

APLS Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Apellis Pharmaceuticals's price over the next three months point to a drop. APLS stock is expected to peak at $26.28 on Mar 25, 2026 before potentially dipping to $3.91 on Jun 04, 2026. On average, APLS is likely to trade around $16.92 in the coming 90 days.

Apellis Pharmaceuticals Stock Forecast 2025

Based on our predictive models, Apellis Pharmaceuticals (APLS) is expected to trade between $0.00 and $26.28 throughout 2026. This would result in an average price of $10.86, potentially offering investors a -46.13% return from current levels.

Apellis Pharmaceuticals, Inc. Monthly Forecast 2026–2027

March 2026

According to our latest forecast models, Apellis Pharmaceuticals, Inc. (APLS) is positioned to show a strong performance in March 2026. The price is predicted to move between $13.90 and $26.28, settling at an average of $20.32. This could translate to a +0.79% gain.

April 2026

Based on current market signals, Apellis Pharmaceuticals, Inc. is projected to trend april 2026. We forecast a trading range from $10.84 to $22.28, with a likely average price of $16.50. Investors could expect a potential return of -18.15%.

May 2026

Our predictive algorithms indicate Apellis Pharmaceuticals, Inc. stock may see a shift in May 2026. The expected range spans $9.24–$21.08, with an average target of $15.41. This represents a cautious outlook and a possible loss of -23.56%.

June 2026

Analyzing established trends, Apellis Pharmaceuticals, Inc. looks set to move in June 2026. Projections place the stock between $1.06 and $16.14, averaging around $9.36. This suggests a -53.57% loss from current levels.

July 2026

Market indicators suggest Apellis Pharmaceuticals, Inc. could experience notable changes during July 2026. Prices could fluctuate within $4.84 to $18.33, with a midpoint forecast of $11.61. The stock might deliver a -42.41% loss.

August 2026

Forecasting for August 2026, models estimate that Apellis Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $5.37 and $18.63, averaging $12.99. This signals a cautious trajectory with potential returns around -35.57%.

September 2026

According to our latest forecast models, Apellis Pharmaceuticals, Inc. (APLS) is positioned to show a strong performance in September 2026. The price is predicted to move between $3.78 and $15.51, settling at an average of $9.23. This could translate to a -54.22% loss.

October 2026

Based on current market signals, Apellis Pharmaceuticals, Inc. is projected to trend october 2026. We forecast a trading range from $0.00 to $13.84, with a likely average price of $7.30. Investors could expect a potential return of -63.79%.

November 2026

Our predictive algorithms indicate Apellis Pharmaceuticals, Inc. stock may see a shift in November 2026. The expected range spans $0.00–$8.19, with an average target of $2.09. This represents a cautious outlook and a possible loss of -89.63%.

December 2026

Analyzing established trends, Apellis Pharmaceuticals, Inc. looks set to move in December 2026. Projections place the stock between $0.00 and $11.97, averaging around $4.75. This suggests a -76.44% loss from current levels.

January 2027

Market indicators suggest Apellis Pharmaceuticals, Inc. could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $12.44, with a midpoint forecast of $5.51. The stock might deliver a -72.67% loss.

February 2027

Forecasting for February 2027, models estimate that Apellis Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $7.54, averaging $2.17. This signals a cautious trajectory with potential returns around -89.24%.

March 2027

According to our latest forecast models, Apellis Pharmaceuticals, Inc. (APLS) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $6.03, settling at an average of $1.17. This could translate to a -94.20% loss.

APLS's history of dividends and stock splits also plays a role in long-term investor confidence.